SEC Form 4 · accession 0001562180-17-003550
ARRAY BIOPHARMA INC · ARRY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gil J Van Lunsen
Director
Period of report
Nov 13, 2017
Accepted (ET)
Nov 13, 2017 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 13, 2017 | D | 1,035 | $10.90 | D | 19,297 | D |
Table II — derivative securities
No Table II lines on this filing.